Article
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.
Cancer letters - 1 Aug 2000
Kuligina E S, Togo A V, Suspitsin E N, Grigoriev M Y, Pozharisskiy K M, Chagunava O L, Berstein L M, Theillet C, Hanson K P, Imyanitov E N
Abstract excerpt
The CYP17 gene encodes an enzyme involved in several critical steps of steroidogenesis. The promoter region of the CYP17 displays a single-nucleotide polymorphism, which is suspected to modulate the expression of the gene and thus may contribute in the interindividual variations of hormonal background. In agreement with this functional hypothesis, the MspA1+ allele (designated as A2) of the CYP17 was shown to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.